A CLINICAL STUDY OF TRIKANTAKADI GUGGULU AND ERVARUBIJADI KWATH ANUPAN IN THE MANAGEMENT OF MUTRAGHAT W.S.R. CHRONIC KIDNEY DISEASE
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Reduce the symptom of CKD
研究概览
简要总结
Mutraghat (chronic kidney disease) is a progressive form of Renal disorder and may appear at the stage of irreversible damage. CKD is identified by Blood test for Creatinine ,which is a breakdown product of muscle metabolism. Higher level of Creatinineindicates a lower GFR and as a resultdecreased capability of the Kidneys to excrete products. The modern method of treatment is not satisfactory for CKD patients and causes many adverse reactions. A total number of 30 patients will be selected for this study and will be advised Trikantakadi gugglu with anupana of Eravarubijadi kwath added with punarnava and cornsilk extract for 60 days. During treatment follow up will be done weekly, and post treatment follow up will be done every 15 days. Assessment will be done on the basis of subjective and objective criteria adopted for this study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Known CKD patients with Blood serum creatinine level less than 5 mg/dl, Blood urea level less than 100 mg/dl, Stable patients of DM type 2 or Hypertension.
排除标准
- •Terminal stage of CKD patients, Ruled out renal stone patients, Patients need for hemodialysis, Blood serum creatinine level more than or equal to 5 mg/dl, Blood urea level more than or equal to 100 mg/dl, GFR less than 30ml/min, Unstable patient of DM type 2 or Hypertension, Cancer, AIDS, Corona.
结局指标
主要结局
Reduce the symptom of CKD
时间窗: 60 days
次要结局
- improve the Quality of Life(60 days)